Chemical ID |
Chemical Name |
Interaction |
Interaction Action |
Publication |
---|
C023514 |
2,6-dinitrotoluene |
2,6-dinitrotoluene results in decreased expression of MAP2 mRNA | decreases expression | 20406850
|
D000643 |
Ammonium Chloride |
Ammonium Chloride affects the expression of MAP2 mRNA | affects expression | 16483693
|
D000643 |
Ammonium Chloride |
Ammonium Chloride results in decreased expression of MAP2 protein | decreases expression | 16483693
|
C006780 |
bisphenol A |
bisphenol A results in decreased expression of MAP2 mRNA | decreases expression | 20678512
|
D002104 |
Cadmium |
Cadmium results in increased expression of MAP2 mRNA | increases expression | 21172416
|
D002211 |
Capsaicin |
Capsaicin results in increased expression of MAP2 mRNA | increases expression | 18405923
|
D010133 |
p-Chloroamphetamine |
p-Chloroamphetamine results in decreased expression of MAP2 mRNA | decreases expression | 17407499
|
D010133 |
p-Chloroamphetamine |
p-Chloroamphetamine results in decreased expression of MAP2 protein | decreases expression | 17407499
|
D002746 |
Chlorpromazine |
Chlorpromazine results in increased expression of MAP2 mRNA | increases expression | 15079866
|
D016572 |
Cyclosporine |
Cyclosporine results in increased expression of MAP2 mRNA | increases expression | 20106945
|
D004178 |
Diquat |
Diquat results in increased expression of MAP2 mRNA | increases expression | 21172416
|
D005472 |
Fluorouracil |
Fluorouracil results in increased expression of MAP2 mRNA | increases expression | 16510598
|
D006220 |
Haloperidol |
Haloperidol results in increased expression of MAP2 mRNA | increases expression | 15079866
|
D008694 |
Methamphetamine |
Methamphetamine results in decreased expression of MAP2 mRNA | decreases expression | 17407499
|
D008694 |
Methamphetamine |
Methamphetamine results in decreased expression of MAP2 protein | decreases expression | 17407499
|
C076029 |
olanzapine |
olanzapine results in increased expression of MAP2 mRNA | increases expression | 15079866
|
C030110 |
oxaliplatin |
oxaliplatin results in increased expression of MAP2 mRNA | increases expression | 16510598
|
C073402 |
PD 123319 |
PD 123319 inhibits the reaction [AGT protein results in increased expression of MAP2 protein] | decreases reaction|increases expression | 17068200
|
C058305 |
phenethyl isothiocyanate |
phenethyl isothiocyanate results in decreased expression of MAP2 mRNA | decreases expression | 17616710
|
D011374 |
Progesterone |
Progesterone results in increased expression of MAP2 mRNA | increases expression | 18037150
|
D018967 |
Risperidone |
Risperidone results in increased expression of MAP2 mRNA | increases expression | 15079866
|
C024746 |
tobacco tar |
tobacco tar results in decreased expression of MAP2 mRNA | decreases expression | 19559774
|
D014212 |
Tretinoin |
[NTF3 protein co-treated with Tretinoin] results in increased expression of MAP2 protein | affects cotreatment|increases expression | 16996685
|
D014212 |
Tretinoin |
Tretinoin results in increased expression of MAP2 protein | increases expression | 15464216
|
D014212 |
Tretinoin |
[Tretinoin co-treated with BDNF protein co-treated with NTF3 protein] results in decreased expression of MAP2 protein | affects cotreatment|decreases expression | 16646665
|
C081489 |
valsartan |
valsartan promotes the reaction [AGT protein results in increased expression of MAP2 protein] | increases expression|increases reaction | 17068200
|
Disease ID |
Disease Name |
Direct Evidence |
Inference Chemical Name |
Inference Score |
Publication |
---|
MESH:D000014 |
Abnormalities, Drug-Induced |
|
Capsaicin |
4.42 | 18926900 |
MESH:D000138 |
Acidosis |
|
Ammonium Chloride |
3.45 | 18287403 |
MESH:D058186 |
Acute Kidney Injury |
|
Capsaicin |
4.44 | 18460982 |
MESH:D000230 |
Adenocarcinoma |
|
Fluorouracil |
2.40 | 17638652 |
MESH:D000505 |
Alopecia |
|
Capsaicin |
9.29 | 17569567 |
MESH:D000505 |
Alopecia |
|
Tretinoin |
9.29 | 15955085 |
MESH:D000740 |
Anemia |
|
Fluorouracil |
3.61 | 15504547 17963324 16511603 |
MESH:D001169 |
Arthritis, Experimental |
|
Tretinoin |
3.01 | 16412693 |
MESH:D001172 |
Arthritis, Rheumatoid |
|
Tretinoin |
2.24 | 16292516 |
MESH:D020817 |
Asperger Syndrome |
|
Risperidone |
5.41 | 16401163 |
MESH:D001249 |
Asthma |
|
Tretinoin |
2.31 | 16456186 |
MESH:D050197 |
Atherosclerosis |
|
Cadmium |
3.58 | 15687053 |
MESH:D001289 |
Attention Deficit Disorder with Hyperactivity |
|
Risperidone |
4.72 | 18349709 |
MESH:D001321 |
Autistic Disorder |
|
Haloperidol |
2.64 | 19368416 18080171 |
MESH:D001321 |
Autistic Disorder |
|
olanzapine |
2.64 | 17069543 18685284 |
MESH:D001321 |
Autistic Disorder |
|
Risperidone |
2.64 | 17019624 15492353 19154706 16239862 15994720 17069546 18775368 19368416 19013209 16379507 19232924 16601648 15930063 15543515 18080171 18349709 18026891 17929164 16948927 16730335 18278980 |
MESH:D001471 |
Barrett Esophagus |
|
Tretinoin |
4.29 | 16935849 |
MESH:D001714 |
Bipolar Disorder |
|
Risperidone |
4.46 | 19154706 18278980 |
MESH:D001778 |
Blood Coagulation Disorders |
|
Tretinoin |
3.51 | 16197459 16206674 |
MESH:D001862 |
Bone Resorption |
|
bisphenol A |
3.76 | 11985600 |
MESH:D001919 |
Bradycardia |
|
Capsaicin |
4.95 | 18207255 |
MESH:D020201 |
Brain Hemorrhage, Traumatic |
|
Progesterone |
5.23 | 17868700 |
MESH:D001930 |
Brain Injuries |
|
Progesterone |
4.15 | 15665606 15380490 15845082 |
MESH:D002545 |
Brain Ischemia |
|
Capsaicin |
4.86 | 19211983 |
MESH:D001943 |
Breast Neoplasms |
|
bisphenol A |
1.98 | 17123778 |
MESH:D001943 |
Breast Neoplasms |
|
Fluorouracil |
1.98 | 18357371 15136595 16110121 19217205 18608205 16595493 16557594 |
MESH:D001943 |
Breast Neoplasms |
|
Progesterone |
1.98 | 15562024 16175315 17614352 |
MESH:D001943 |
Breast Neoplasms |
|
Tretinoin |
1.98 | 16443354 16166294 16873071 |
MESH:D001997 |
Bronchopulmonary Dysplasia |
|
Tretinoin |
4.48 | 16813970 |
MESH:D002276 |
Carcinoid Tumor |
|
Fluorouracil |
4.56 | 16051944 |
MESH:D002277 |
Carcinoma |
|
Fluorouracil |
3.48 | 17121937 |
MESH:D018236 |
Carcinoma, Embryonal |
|
Tretinoin |
5.05 | 16168501 |
MESH:D006528 |
Carcinoma, Hepatocellular |
|
2,6-dinitrotoluene |
4.52 | 16705839 |
MESH:D006528 |
Carcinoma, Hepatocellular |
|
Fluorouracil |
4.52 | 16799960 16332177 17088986 17045692 17971768 18930000 |
MESH:D006528 |
Carcinoma, Hepatocellular |
|
Tretinoin |
4.52 | 1917145 |
MESH:D002278 |
Carcinoma in Situ |
|
bisphenol A |
4.88 | 17123778 |
MESH:D002292 |
Carcinoma, Renal Cell |
|
Fluorouracil |
2.97 | 18695887 |
MESH:D002294 |
Carcinoma, Squamous Cell |
|
Fluorouracil |
4.62 | 17066447 16757204 18986760 16280240 |
MESH:D002294 |
Carcinoma, Squamous Cell |
|
Tretinoin |
4.62 | 16051514 16096774 |
MESH:D006332 |
Cardiomegaly |
|
valsartan |
4.12 | 19597038 |
MESH:D009202 |
Cardiomyopathies |
|
valsartan |
4.36 | 16247790 |
MESH:D002318 |
Cardiovascular Diseases |
|
valsartan |
4.22 | 11230374 |
MESH:D002375 |
Catalepsy |
|
Haloperidol |
4.80 | 1977408 15215559 |
MESH:D002386 |
Cataract |
|
Tretinoin |
3.03 | 17460283 |
MESH:D002389 |
Catatonia |
|
olanzapine |
6.14 | 18071103 16772815 |
MESH:D002471 |
Cell Transformation, Neoplastic |
|
2,6-dinitrotoluene |
15.48 | 6135515 |
MESH:D002471 |
Cell Transformation, Neoplastic |
|
Cadmium |
15.48 | 17332340 |
MESH:D002471 |
Cell Transformation, Neoplastic |
|
Cyclosporine |
15.48 | 12371664 |
MESH:D002471 |
Cell Transformation, Neoplastic |
|
tobacco tar |
15.48 | 19559774 |
MESH:D018290 |
Cervical Intraepithelial Neoplasia |
|
Tretinoin |
4.48 | 16129372 |
MESH:D002779 |
Cholestasis |
|
Cyclosporine |
2.83 | 19486331 |
MESH:D002822 |
Choriocarcinoma |
|
Tretinoin |
5.05 | 16461808 |
MESH:D002972 |
Cleft Palate |
|
Tretinoin |
2.62 | 9407595 |
MESH:D003092 |
Colitis |
|
Tretinoin |
3.60 | 17035595 |
MESH:D003093 |
Colitis, Ulcerative |
|
phenethyl isothiocyanate |
3.61 | 20423518 |
MESH:D003110 |
Colonic Neoplasms |
|
Fluorouracil |
4.11 | 17287894 15001691 16340194 17169374 17172411 17725105 18772588 16510598 17016597 17018589 |
MESH:D003110 |
Colonic Neoplasms |
|
oxaliplatin |
4.11 | 16510598 16024531 16004971 |
MESH:D015179 |
Colorectal Neoplasms |
|
Fluorouracil |
2.92 | 17016601 17695437 17094418 16524972 18802399 16331619 17255274 20501625 18448328 17454858 14970324 18509181 15289873 15148649 16391804 17401013 18949393 16303861 18383874 16282729 17594712 18288408 |
MESH:D015179 |
Colorectal Neoplasms |
|
oxaliplatin |
2.92 | 18509181 17594712 17695437 17255274 17401013 18448328 |
MESH:D003324 |
Coronary Artery Disease |
|
valsartan |
3.86 | 17719468 |
MESH:D003371 |
Cough |
|
Capsaicin |
5.07 | 10350223 |
MESH:D003384 |
Coxsackievirus Infections |
|
valsartan |
5.73 | 20392896 |
MESH:D019465 |
Craniofacial Abnormalities |
|
Tretinoin |
1.81 | 9211117 14991402 17551590 9664655 16925845 9125849 10589399 8800419 9224671 9142499 |
MESH:D003490 |
Cyanosis |
|
2,6-dinitrotoluene |
3.91 | 18551238 |
MESH:D007644 |
Darier Disease |
|
Fluorouracil |
4.68 | 16733453 |
MESH:D016757 |
Death, Sudden, Cardiac |
|
Haloperidol |
11.11 | 20210726 |
MESH:D016757 |
Death, Sudden, Cardiac |
|
Risperidone |
11.11 | 20210726 |
MESH:D003704 |
Dementia |
|
Haloperidol |
10.21 | 11575062 |
MESH:D003704 |
Dementia |
|
Risperidone |
10.21 | 11575062 |
MESH:D002658 |
Developmental Disabilities |
|
olanzapine |
4.62 | 17069543 |
MESH:D003921 |
Diabetes Mellitus, Experimental |
|
valsartan |
4.51 | 11508273 |
MESH:D003928 |
Diabetic Nephropathies |
|
valsartan |
4.70 | 11427623 18630688 |
MESH:D003929 |
Diabetic Neuropathies |
|
Progesterone |
4.38 | 17187935 |
MESH:D006970 |
Disorders of Excessive Somnolence |
|
Risperidone |
6.22 | 16379507 |
MESH:D053207 |
Diurnal Enuresis |
|
Risperidone |
6.57 | 17822346 |
MESH:D004314 |
Down Syndrome |
|
Risperidone |
4.98 | 18349709 |
MESH:D056486 |
Drug-Induced Liver Injury |
|
2,6-dinitrotoluene |
6.47 | 18551238 21346803 |
MESH:D056486 |
Drug-Induced Liver Injury |
|
Chlorpromazine |
6.47 | 11461765 |
MESH:D056486 |
Drug-Induced Liver Injury |
|
Diquat |
6.47 | 18445702 18164269 |
MESH:D004381 |
Duodenal Ulcer |
|
Capsaicin |
4.58 | 11535926 10671773 |
MESH:D004489 |
Edema, Cardiac |
|
Tretinoin |
4.36 | 18230668 |
MESH:D004681 |
Encephalomyelitis, Autoimmune, Experimental |
|
Progesterone |
3.67 | 17692515 |
MESH:D016889 |
Endometrial Neoplasms |
|
Tretinoin |
3.04 | 16569247 |
MESH:D004715 |
Endometriosis |
|
Progesterone |
3.67 | 16134523 |
MESH:D004935 |
Esophageal Diseases |
|
Capsaicin |
5.59 | 19566590 |
MESH:D004938 |
Esophageal Neoplasms |
|
Fluorouracil |
2.42 | 16785472 15173087 17638652 16337965 16481741 |
MESH:D005124 |
Eye Abnormalities |
|
Tretinoin |
3.49 | 16938888 9664655 |
MESH:D005234 |
Fatty Liver |
|
Cyclosporine |
2.76 | 19224547 |
MESH:D005355 |
Fibrosis |
|
Cyclosporine |
14.33 | 12168785 12639820 |
MESH:D005355 |
Fibrosis |
|
Tretinoin |
14.33 | 17994277 |
MESH:D005355 |
Fibrosis |
|
valsartan |
14.33 | 16893502 |
MESH:D005756 |
Gastritis |
|
Diquat |
5.47 | 15046732 |
MESH:D005885 |
Gingival Hyperplasia |
|
Cyclosporine |
4.11 | 8708960 |
MESH:D005909 |
Glioblastoma |
|
Capsaicin |
7.29 | 18405923 |
MESH:D005909 |
Glioblastoma |
|
Tretinoin |
7.29 | 17312396 |
MESH:D005910 |
Glioma |
|
Fluorouracil |
2.83 | 16145905 |
MESH:D015432 |
Glomerulonephritis, Membranoproliferative |
|
valsartan |
5.43 | 16928621 |
MESH:D006258 |
Head and Neck Neoplasms |
|
Fluorouracil |
7.55 | 15162350 18337622 15102660 |
MESH:D006258 |
Head and Neck Neoplasms |
|
Tretinoin |
7.55 | 16096774 |
MESH:D006317 |
Hearing Loss, Noise-Induced |
|
Tretinoin |
5.05 | 16084493 |
MESH:D006356 |
Heartburn |
|
Capsaicin |
5.59 | 19566590 |
MESH:D006330 |
Heart Defects, Congenital |
|
Tretinoin |
2.84 | 14991402 9664655 |
MESH:D006333 |
Heart Failure |
|
valsartan |
4.18 | 19027736 |
MESH:D006457 |
Hemoglobinuria, Paroxysmal |
|
Cyclosporine |
4.31 | 15720958 |
MESH:D006561 |
Herpes Simplex |
|
Chlorpromazine |
5.18 | 1682908 |
MESH:D006930 |
Hyperalgesia |
|
Capsaicin |
12.86 | 17434803 17043245 |
MESH:D006930 |
Hyperalgesia |
|
oxaliplatin |
12.86 | 17418472 |
MESH:D006930 |
Hyperalgesia |
|
Tretinoin |
12.86 | 16870215 |
MESH:D017681 |
Hypereosinophilic Syndrome |
|
Tretinoin |
4.46 | 16778211 |
MESH:D006943 |
Hyperglycemia |
|
Risperidone |
5.06 | 18278980 |
MESH:D006948 |
Hyperkinesis |
|
Methamphetamine |
5.40 | 17658665 |
MESH:D006963 |
Hyperphagia |
|
olanzapine |
6.12 | 17933447 |
MESH:D006973 |
Hypertension |
|
Cyclosporine |
5.48 | 10903974 |
MESH:D006973 |
Hypertension |
|
valsartan |
5.48 | 16475468 20102058 12850387 11427623 18390891 12692753 18344623 10903974 |
MESH:D006974 |
Hypertension, Malignant |
|
valsartan |
6.31 | 11560862 |
MESH:D020244 |
Infarction, Middle Cerebral Artery |
|
Progesterone |
4.29 | 15869954 |
MESH:D007248 |
Infertility, Male |
|
Diquat |
4.22 | 4850670 |
MESH:D007249 |
Inflammation |
|
Capsaicin |
5.41 | 16956363 |
MESH:D007249 |
Inflammation |
|
Progesterone |
5.41 | 15869954 |
MESH:D007333 |
Insulin Resistance |
|
bisphenol A |
3.22 | 16393666 |
MESH:D007410 |
Intestinal Diseases |
|
Tretinoin |
3.66 | 17994277 |
MESH:D007569 |
Jaw Abnormalities |
|
Tretinoin |
3.80 | 17551590 15992940 |
MESH:D007638 |
Keratoconjunctivitis Sicca |
|
Cyclosporine |
4.34 | 15604871 |
MESH:D007674 |
Kidney Diseases |
|
Cadmium |
9.97 | 16962696 16226777 16322080 |
MESH:D007674 |
Kidney Diseases |
|
Cyclosporine |
9.97 | 18776723 10903974 8314463 |
MESH:D007674 |
Kidney Diseases |
|
valsartan |
9.97 | 12164870 16893502 10903974 |
MESH:D007680 |
Kidney Neoplasms |
|
2,6-dinitrotoluene |
11.88 | 16705839 |
MESH:D007680 |
Kidney Neoplasms |
|
Cyclosporine |
11.88 | 12371664 |
MESH:D007680 |
Kidney Neoplasms |
|
Fluorouracil |
11.88 | 16985049 |
MESH:D007938 |
Leukemia |
|
Tretinoin |
2.72 | 17143497 |
MESH:D007951 |
Leukemia, Myeloid |
|
Tretinoin |
3.60 | 16482212 16932348 19285840 |
MESH:D015470 |
Leukemia, Myeloid, Acute |
|
Tretinoin |
2.06 | 17596541 16294345 19850784 |
MESH:D015473 |
Leukemia, Promyelocytic, Acute |
|
Tretinoin |
3.08 | 17339181 17712046 17217047 19642359 17506722 17649720 17368321 16823087 17301526 17294898 16935935 16788101 19029980 19035177 16140955 17361223 15748426 9834237 17107899 19075265 19225113 16891316 16766008 16331271 12679006 |
MESH:D017880 |
Limb Deformities, Congenital |
|
Tretinoin |
3.23 | 9224671 |
MESH:D008064 |
Lipidoses |
|
Chlorpromazine |
4.67 | 15342952 17567588 |
MESH:D008106 |
Liver Cirrhosis, Experimental |
|
Tretinoin |
2.94 | 16248980 18397230 |
MESH:D008106 |
Liver Cirrhosis, Experimental |
|
valsartan |
2.94 | 15504291 15619341 16872305 |
MESH:D008107 |
Liver Diseases |
|
Capsaicin |
4.99 | 16956363 |
MESH:D008107 |
Liver Diseases |
|
Chlorpromazine |
4.99 | 14986274 |
MESH:D008113 |
Liver Neoplasms |
|
2,6-dinitrotoluene |
4.52 | 7678174 |
MESH:D008113 |
Liver Neoplasms |
|
Fluorouracil |
4.52 | 16603448 17045692 15113037 18383874 |
MESH:D008114 |
Liver Neoplasms, Experimental |
|
2,6-dinitrotoluene |
2.48 | 2876786 2876784 6135515 |
MESH:D008133 |
Long QT Syndrome |
|
olanzapine |
4.64 | 20210726 |
MESH:D008175 |
Lung Neoplasms |
|
Fluorouracil |
2.00 | 15246190 |
MESH:D008178 |
Lupus Erythematosus, Cutaneous |
|
Fluorouracil |
4.68 | 15086387 |
MESH:D008325 |
Mammary Neoplasms, Experimental |
|
Progesterone |
2.80 | 11408345 17203775 |
MESH:D008527 |
Medulloblastoma |
|
Tretinoin |
2.74 | 17453147 |
MESH:D008545 |
Melanoma |
|
Tretinoin |
1.93 | 16752155 |
MESH:D008591 |
Meningomyelocele |
|
Tretinoin |
4.32 | 16940565 |
MESH:D001523 |
Mental Disorders |
|
Chlorpromazine |
18.00 | 16856516 |
MESH:D001523 |
Mental Disorders |
|
Haloperidol |
18.00 | 16856516 |
MESH:D001523 |
Mental Disorders |
|
olanzapine |
18.00 | 16856516 |
MESH:D001523 |
Mental Disorders |
|
Risperidone |
18.00 | 16596465 16856516 |
MESH:D008607 |
Mental Retardation |
|
Risperidone |
4.07 | 18349709 |
MESH:D008659 |
Metabolic Diseases |
|
olanzapine |
5.29 | 19142110 |
MESH:D024821 |
Metabolic Syndrome X |
|
Risperidone |
5.09 | 19142101 |
MESH:D008664 |
Metal Metabolism, Inborn Errors |
|
Cyclosporine |
4.68 | 16801185 |
MESH:D019964 |
Mood Disorders |
|
Risperidone |
5.72 | 17019624 |
MESH:D009062 |
Mouth Neoplasms |
|
Fluorouracil |
3.55 | 16757204 18986760 |
MESH:D009101 |
Multiple Myeloma |
|
Capsaicin |
4.08 | 17505005 |
MESH:D009175 |
Mycoplasma Infections |
|
Chlorpromazine |
5.89 | 10773494 |
MESH:D009190 |
Myelodysplastic Syndromes |
|
Tretinoin |
3.02 | 17596541 |
MESH:D009336 |
Necrosis |
|
2,6-dinitrotoluene |
3.75 | 7678174 18551238 |
MESH:D009369 |
Neoplasms |
|
Fluorouracil |
4.97 | 18239605 18600527 16928823 |
MESH:D009369 |
Neoplasms |
|
Tretinoin |
4.97 | 16594593 16946489 |
MESH:D009402 |
Nephrosis, Lipoid |
|
Cyclosporine |
4.34 | 17954296 |
MESH:D009404 |
Nephrotic Syndrome |
|
Cyclosporine |
3.19 | 19348381 18481113 |
MESH:D009421 |
Nervous System Malformations |
|
bisphenol A |
9.43 | 16427766 11399458 |
MESH:D009421 |
Nervous System Malformations |
|
Tretinoin |
9.43 | 9125849 |
MESH:D009436 |
Neural Tube Defects |
|
Tretinoin |
2.98 | 9142499 |
MESH:D020078 |
Neurogenic Inflammation |
|
Capsaicin |
4.98 | 17961222 |
MESH:D020258 |
Neurotoxicity Syndromes |
|
Fluorouracil |
3.36 | 16436463 |
MESH:D053206 |
Nocturnal Enuresis |
|
Risperidone |
6.22 | 17822346 |
MESH:D009765 |
Obesity |
|
Capsaicin |
5.45 | 19056576 |
MESH:D009765 |
Obesity |
|
olanzapine |
5.45 | 18515891 |
MESH:D009784 |
Occupational Diseases |
|
2,6-dinitrotoluene |
3.33 | 16049721 |
MESH:D010049 |
Ovarian Diseases |
|
bisphenol A |
4.88 | 11985600 |
MESH:D010051 |
Ovarian Neoplasms |
|
Progesterone |
4.80 | 17393432 16525653 |
MESH:D010051 |
Ovarian Neoplasms |
|
Tretinoin |
4.80 | 16936753 |
MESH:D010146 |
Pain |
|
Capsaicin |
6.88 | 17434803 17084039 19081190 17043245 18987195 16996476 |
MESH:D010146 |
Pain |
|
Tretinoin |
6.88 | 16870215 |
MESH:D010190 |
Pancreatic Neoplasms |
|
Fluorouracil |
5.21 | 16500647 19003803 16929163 15113037 |
MESH:D010190 |
Pancreatic Neoplasms |
|
Tretinoin |
5.21 | 15976015 |
MESH:D016491 |
Peripheral Vascular Diseases |
|
Cadmium |
5.27 | 15687053 |
MESH:D011230 |
Precancerous Conditions |
|
Cyclosporine |
3.13 | 12371664 |
MESH:D011297 |
Prenatal Exposure Delayed Effects |
|
bisphenol A |
3.84 | 10548101 |
MESH:D019048 |
Prostatic Intraepithelial Neoplasia |
|
bisphenol A |
4.10 | 20887781 |
MESH:D011471 |
Prostatic Neoplasms |
|
bisphenol A |
2.75 | 16740699 |
MESH:D011471 |
Prostatic Neoplasms |
|
Cadmium |
2.75 | 17075824 |
MESH:D011471 |
Prostatic Neoplasms |
|
Fluorouracil |
2.75 | 18626508 19082440 |
MESH:D011507 |
Proteinuria |
|
Tretinoin |
9.24 | 16636307 |
MESH:D011507 |
Proteinuria |
|
valsartan |
9.24 | 17664856 12164870 18344623 |
MESH:D011565 |
Psoriasis |
|
Cyclosporine |
2.19 | 16882103 |
MESH:D011595 |
Psychomotor Agitation |
|
Haloperidol |
11.45 | 11575062 |
MESH:D011595 |
Psychomotor Agitation |
|
olanzapine |
11.45 | 18685284 |
MESH:D011618 |
Psychotic Disorders |
|
Haloperidol |
4.17 | 11575062 |
MESH:D011625 |
Pterygium |
|
Tretinoin |
4.68 | 16723453 |
MESH:D011629 |
Puberty, Precocious |
|
bisphenol A |
4.68 | 10548101 |
MESH:D011658 |
Pulmonary Fibrosis |
|
valsartan |
3.77 | 17241526 |
MESH:D012004 |
Rectal Neoplasms |
|
Fluorouracil |
3.92 | 18722050 15538739 18286688 16160472 |
MESH:D015427 |
Reperfusion Injury |
|
Capsaicin |
3.91 | 19211983 18460982 |
MESH:D012208 |
Rhabdomyosarcoma |
|
Tretinoin |
3.99 | 16283617 16116481 |
MESH:D012468 |
Salivary Gland Neoplasms |
|
Progesterone |
2.82 | 18045962 |
MESH:D012559 |
Schizophrenia |
|
Haloperidol |
5.91 | 19369910 1830565 20107430 18513383 |
MESH:D012559 |
Schizophrenia |
|
olanzapine |
5.91 | 20107430 20521326 17726453 |
MESH:D012559 |
Schizophrenia |
|
Risperidone |
5.91 | 20107430 18278980 19154706 |
MESH:D012640 |
Seizures |
|
2,6-dinitrotoluene |
2.46 | 18551238 |
MESH:D012878 |
Skin Neoplasms |
|
Tretinoin |
2.56 | 16467112 |
MESH:D012893 |
Sleep Disorders |
|
Risperidone |
5.40 | 18278980 |
MESH:D013119 |
Spinal Cord Injuries |
|
Progesterone |
4.17 | 16503802 15862959 |
MESH:D013274 |
Stomach Neoplasms |
|
Fluorouracil |
2.48 | 17522103 16951190 17172411 19015929 18396642 18567086 16424979 17498489 15786421 19084572 |
MESH:D013274 |
Stomach Neoplasms |
|
Tretinoin |
2.48 | 17261132 |
MESH:D019966 |
Substance-Related Disorders |
|
bisphenol A |
3.88 | 16045194 16684133 |
MESH:D017180 |
Tachycardia, Ventricular |
|
Haloperidol |
17.05 | 20210726 |
MESH:D017180 |
Tachycardia, Ventricular |
|
olanzapine |
17.05 | 20210726 |
MESH:D017180 |
Tachycardia, Ventricular |
|
Risperidone |
17.05 | 20210726 |
MESH:D013705 |
Temporomandibular Joint Disorders |
|
Capsaicin |
5.62 | 17997062 |
MESH:D013733 |
Testicular Diseases |
|
phenethyl isothiocyanate |
4.83 | 15864552 |
MESH:D013964 |
Thyroid Neoplasms |
|
Tretinoin |
2.94 | 17045167 16026305 |
MESH:D014062 |
Tongue Neoplasms |
|
Fluorouracil |
9.50 | 16280240 |
MESH:D014062 |
Tongue Neoplasms |
|
Tretinoin |
9.50 | 16051514 |
MESH:D005879 |
Tourette Syndrome |
|
Risperidone |
5.83 | 19154706 |
MESH:D014376 |
Tuberculosis |
|
Tretinoin |
3.16 | 16040207 |
MESH:D001749 |
Urinary Bladder Neoplasms |
|
2,6-dinitrotoluene |
2.25 | 16049721 |
MESH:D014571 |
Urologic Neoplasms |
|
2,6-dinitrotoluene |
4.21 | 10091137 |
MESH:D002583 |
Uterine Cervical Neoplasms |
|
Fluorouracil |
9.12 | 16803524 |
MESH:D002583 |
Uterine Cervical Neoplasms |
|
Tretinoin |
9.12 | 16129372 |
MESH:D014591 |
Uterine Diseases |
|
bisphenol A |
4.90 | 14652134 |
MESH:D014604 |
Uveal Neoplasms |
|
Tretinoin |
4.50 | 16752155 |
MESH:D014605 |
Uveitis |
|
Cyclosporine |
3.88 | 1336536 |
MESH:D020257 |
Ventricular Remodeling |
|
valsartan |
5.59 | 19027736 |
MESH:D014820 |
Vitiligo |
|
Tretinoin |
3.95 | 16761959 |
MESH:D015430 |
Weight Gain |
|
olanzapine |
10.32 | 20107430 19434072 17933447 |
MESH:D015430 |
Weight Gain |
|
Risperidone |
10.32 | 16379507 20564506 |
MESH:D009396 |
Wilms Tumor |
|
Tretinoin |
3.87 | 16287080 |
MESH:D014985 |
Xerophthalmia |
|
Cyclosporine |
4.34 | 17120751 |